VEGFA and neoplasm: The potential mechanisms by which tumor cells can evade antiangiogenic therapy include upregulation of non-VEGF-mediated pathways of angiogenesis, recruitment of bone marrow-derived cells, increased pericyte coverage, and increased use of preexistent vasculature by invasion [3].